Company Projected Revenue: Citius Pharmaceuticals Inc. (CTXR)

Citius Pharmaceuticals develops advanced treatments for oncology-dependent conditions through R&D of biodegradable gels. Revenue is based on the development of drugs targeting lymphomas and catheter-related infections. However, the firm's survival depends on regulatory approval and product launch costs. The company's projected sales illustrate the market reaction to these inputs, where 0.01 forms the current metric indicator.

Company Expected Sales Volume: Citius Pharmaceuticals (CTXR) for 07/04/2022 - 11/15/2026

Summary analytical data breakdowns for Citius Pharmaceuticals, Inc. (CTXR)

- stock value and consensus price forecast:

Price Chart Citius Pharmaceuticals|CTXR - Average Forecast Price

- company stock exchange capitalization indicators:

Market Value Citius Pharmaceuticals, Inc.|CTXR - Total Company Value

- balance sheet equity data:

Net Assets per Single Share Citius Pharmaceuticals|CTXR - Total Stockholders' Equity|Market Capitalization to Book Value Ratio citiuspharma.com|CTXR - Company Balance Sheet Assets

- debt obligations and liquidity statistics:

Total Debt to Equity Ratio Citius Pharmaceuticals|CTXR - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Citius Pharmaceuticals Inc.|CTXR - Aggregate Debt Obligations|Debt to Book Value Citius Pharmaceuticals Inc.|CTXR - Amount of Long-Term Liabilities|Company Short-Term Debts Citius Pharmaceuticals|Quick Ratio citiuspharma.com

- company profitability and valuation multiples indicators:

CTXR - Company Net Income|Expected Profit Citius Pharmaceuticals|CTXR - Company Value to Net Income|Forward P/E Multiple citiuspharma.com|CTXR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Citius Pharma|CTXR - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Citius Pharmaceuticals|CTXR - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth citiuspharma.com|CTXR - Net earnings per share growth this year|Earnings growth forecast for next year Citius Pharmaceuticals

- sales and revenue data:

CTXR - Company Gross Revenue|Company Future Sales Volume Citius Pharmaceuticals|CTXR - Market Cap to Sales Volume|Forward P/S Multiple Citius Pharmaceuticals, Inc.|CTXR - Annual Revenue Growth (Last Twelve Months)

Fundamental valuation:Citius Pharmaceuticals, Inc. CTXR

Investors evaluate Citius Pharmaceuticals (CTXR) through the lens of its high scientific authority in developing oncology therapies. This indicator models expected revenue by correlating the market value of shares with macroeconomic variables and US Fed rates. An analysis of the company's target sales volumes allows for the identification of deviations in fundamental value from the statistical norm. For biopharmaceuticals, such a metric reflects the commercial potential of life-saving drugs. The stability of this indicator confirms the long-term sustainability of the business model.

Key competitors